Skip Navigation
Skip to contents

Chonnam Med J.  2011 Aug;47(2):66-71. 10.4068/cmj.2011.47.2.66.

Vascular Dementia

Affiliations
  • 1Department of Neurology, Chungnam National University College of Medicine, Daejeon, Korea. aelee@cnu.ac.kr

Abstract

Cerebrovascular disease is the second leading cause of cognitive impairment in the elderly, either alone or in combination with Alzheimer's disease (AD). Vascular dementia (VaD) is heterogeneous in terms of both clinical phenotype and pathogenetic mechanisms. It may result from multiple cortical infarctions due to cerebral large vessel pathologies or to subcortical ischemic changes such as leukoaraiosis or lacunar infarction due to cerebral small artery disease. Clinical symptoms and signs vary depending on the location and size of the stroke lesion, and no single neuropsychological profile characteristic of VaD has been defined, although dysexecutive function is common. A slightly higher mortality rate and slower progression are reported in VaD compared with AD. VaD is potentially preventable by rigorous identification and treatment of cardiovascular disease risk factors, and modest symptomatic improvement with cholinesterase inhibitors has been reported.

Keyword

Vascular dementia; Executive function; Cerebrovascular disorders

MeSH Terms

Aged
Alzheimer Disease
Arteries
Cardiovascular Diseases
Cerebrovascular Disorders
Cholinesterase Inhibitors
Dementia, Vascular
Executive Function
Glycosaminoglycans
Humans
Infarction
Leukoaraiosis
Phenotype
Risk Factors
Stroke
Stroke, Lacunar
Cholinesterase Inhibitors
Glycosaminoglycans
Full Text Links
  • CMJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2026 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr